CoChat

Biological variation estimates of Alzheimer's disease plasma biomarkers in healthy individuals

Open access
Brum, Wagner S., Ashton, Nicholas J., Simrén, Joel, di Molfetta, Guiglielmo, Karikari, Thomas K., Benedet, Andrea L., Zimmer, Eduardo R., Lantero‐Rodriguez, Juan, Montoliu‐Gaya, Laia, Jeromin, Andreas, Aarsand, Aasne K., Bartlett, William A., Calle, Pilar Fernández, Coşkun, Abdurrahman, Díaz–Garzón, Jorge, Jonker, Niels, Zetterberg, Henrik, Sandberg, Sverre, Carobene, Anna, Blennow, Kaj · 2024 · Alzheimer's & Dementia
Cited by 76

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: Blood biomarkers have proven useful in Alzheimer's disease (AD) research. However, little is known about their biological variation (BV), which improves the interpretation of individual‐level data. METHODS: We measured plasma amyloid beta (Aβ42, Aβ40), phosphorylated tau (p‐tau181, p‐tau217, p‐tau231), glial fibrillary acidic protein (GFAP), and neurofilament light chain (NfL) in plasma samples collected weekly over 10 weeks from 20 participants aged 40 to 60 years from the European Biological Variation Study. We estimated within‐ (CV I ) and between‐subject (CV G ) BV, analytical variation, and reference change values (RCV). RESULTS: Biomarkers presented considerable variability in CV I and CV G . Aβ42/Aβ40 had the lowest CV I (≈ 3%) and p‐tau181 the highest (≈ 16%), while others ranged from 6% to 10%. Most RCVs ranged from 20% to 30% (decrease) and 25% to 40% (increase). DISCUSSION: BV estimates for AD plasma biomarkers can potentially refine their clinical and research interpretation. RCVs might be useful for detecting significant changes between serial measurements when monitoring early disease progression or interventions. Highlights: Plasma amyloid beta (Aβ42/Aβ40) presents the lowest between‐ and within‐subject biological variation, but also changes the least in Alzheimer's disease (AD) patients versus controls. Plasma phosphorylated tau variants significantly vary in their within‐subject biological variation, but their substantial fold‐changes in AD likely limits the impact of their variability. Plasma neurofilament light chain and glial fibrillary acidic protein demonstrate high between‐subject variation, the impact of which will depend on clinical context. Reference change values can potentially be useful in monitoring early disease progression and the safety/efficacy of interventions on an individual level. Serial sampling revealed that unexpectedly high values in heathy individuals can be observed, which urges caution when interpreting AD plasma biomarkers based on a single test result.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/alz.13518

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Cited by

Metadata

Authors
Brum, W. S., Ashton, N. J., Simrén, J., di Molfetta, G., Karikari, T. K., Benedet, A. L., Zimmer, E. R., Lantero‐Rodriguez, J., Montoliu‐Gaya, L., Jeromin, A., Aarsand, A. K., Bartlett, W. A., Calle, P. F., Coşkun, A., Díaz–Garzón, J., Jonker, N., Zetterberg, H., Sandberg, S., Carobene, A., & Blennow, K.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2023-11-20
Volume
20
Issue
2
Pages
1284-1297
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W4388851280
Cited by
76
References
42
FWCI
11.01
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.